We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[The hearing screening program for newborns with otoacoustic emission for early detection of hearing loss].
Harefuah 2002 July
The importance of early detection of hearing loss is well known and screening programs for newborns are becoming more common throughout the world. The Hadassah hearing screening program for newborns using the Transient Evoked Otoacoustic Emission (TEOAE) test began in October 1999. All newborns are tested before discharge from the hospital. In case of inadequate results, the infant is scheduled for follow-up in 4 weeks in the Speech and Hearing Center, and according to results, a full audiological evaluation is performed. The high-risk population is also scheduled for follow-up. The preliminary results from 8,982 newborns show that 93.5% passed the screening in the maternity ward, 4.2% failed unilaterally, and 2.2% failed bilaterally. The follow-up rate was low in the beginning, and improved due to proceeding letters and phone calls. The follow-up results show that we were able to detect 6 infants with a hearing loss under the age of 3 months, 4 of these infants belong to the high-risk group. We believe that TEOAE hearing screening for newborns is feasible and can help to detect hard of hearing children earlier than in the past. Undoubtedly, cost effectiveness considerations will be involved in implementation decisions.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app